Blogs

OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the high-performance OptraSCAN Digital pathology platform to enhance care for their patient population. The capabilities of this digital pathology platform improve accessibility to healthcare and the distributed care model. The demand for digital pathology has increased as healthcare institutions have struggled …

Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care Read More »

OptraSCAN® a leading end-to-end digital pathology solution provider has received CE-IVDR marking for the OS-Ultra™ scanners, its high-performance product line of brightfield scanners at an extremely affordable price point, including pay-per-scan based OPEX models. OS Ultra™ scanners have a loading capacity of 80 to 480 slides. With no-touch continuous loading, it scans tissues or cells …

OptraSCAN® receives CE-IVDR for OS-Ultra™ high-performance Digital Pathology System Read More »

OptraSCAN®, the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent – No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned image …

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time Read More »

    Cervical cancer is the second most common gynecologic cancer worldwide. This cancer, unlike the others, does not show any symptoms in its early stage, resulting in increased mortality among women. Cervical cancer can be prevented if effective screening measures are set up. Manual analysis of cytology specimens is extremely tedious, time-consuming and prone …

CytoSiA – To Advance Cytology Screening Through Unmatched Image Quality And Artificial Intelligence Based Image Analysis Solution Read More »

OptraSCAN’s latest addition OS-Ultra modes are designed to assist pathologist to scan images of Immunohistochemistry, HnE and cytology slides in less than 60 seconds. ​OS-Ultra is a high-speed whole slide digital pathology scanner that scans tissues/cells of size 15×15 mm area at 40x equivalent in less than 60 seconds. OS-Ultra features a unique no-touch slide …

OptraSCAN Is Disrupting the Digital Pathology Space with Ultra-Fast Scanners Read More »

​Digital Pathology has offered tremendous opportunities to pathologists, be it in the laboratories, universities, or even research centers. It has unlocked new possibilities not only for day-to-day reporting but also for a remote or expert consultation indeveloping economiesor developed economies. Integration of machine learning and artificial intelligence technologies are assisting pathologists to make an informed …

The Need for Telepathology In Developing Countries Read More »

It is universally known that Digital Pathology (DP) is the process by which glass slides are digitized to produce high-resolution images. However, the promise of digital pathology and the paradigm shift from microscopy to digitization is not merely transfer of an image from glass slide to a monitor; or to share, modify or analyze the …

AI-enabled scanner: an example of the machine learning paradigm of feature learning Read More »

Many healthcare organizations across the globe today are shifting towards digitizing the age-old practice of scanning and viewing glass slides through microscopes. They have realized the potential of digital pathology and digitization of slides that has a direct impact in productivity and efficiency gain. There’s no doubt that digital pathology is bringing a paradigm shift …

Digital Lab-as-a-Service – a convenient way to adopt digital pathology systems Read More »

The field of immune-oncology biomarker is exploding dramatically. Immunotherapy agents overcome tumor evasion through targeted immune checkpoint inhibitors and scientifically driven combination therapies including multiple immune-stimulating and chemotherapeutic agents. However, not all patients are benefited from immunotherapy and precision medicine requires tremendous understanding of the tumor microenvironment. Complex tissue architecture, heterogeneous biomarker expression as well as visual …

OptraSCAN immune-oncology solution for Programmed Death Ligand 1 expression on tumor and immune cells Read More »

Penetration of digital pathology in North America and Europe in research centers, laboratories, and universities is on rise in the recent years. Digital pathology is predicted to follow the successful path of radiology in near future in terms of acceptance. It has been possible due to obvious advantages over conventional microscopy. The possibility to scan …

Role of digital pathology in improving healthcare in developing nations Read More »